HC Wainwright Has Optimistic Opinion of AGMB FY2026 EarningsAgomAb Therapeutics NV (NASDAQ:AGMB - Free Report) - Research analysts at HC Wainwright boosted their FY2026 EPS estimates for shares of AgomAb Therapeutics in a research note issued on Monday, November 16th. HC Wainwright analyst P. Trucchio now anticipates that the company will post earnings per s...